Taken together, knockdown of HMGCS2 attenuated cynaroside’s effects on liver injury and dyslipidemia in C57BL/6J mice with NASH combined with T2DM. The gene discussed is HMGCS2; the disease is metabolic dysfunction-associated steatohepatitis.